MFDS — authorised 2 October 2018
- Marketing authorisation holder: PARATEK PHARMS INC
- Status: likely_approved
MFDS authorised Nuzyra on 2 October 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 2 October 2018.
PARATEK PHARMS INC holds the South Korean marketing authorisation.